Shigeyasu Tsuda
About
In The Last Decade
Shigeyasu Tsuda
20 papers receiving 514 citations
Peers
Comparison fields: 5 of 78
- Pulmonary and Respiratory Medicine 263
- Oncology 233
- Surgery 232
- Pathology and Forensic Medicine 82
- Molecular Biology 66
Countries citing papers authored by Shigeyasu Tsuda
This map shows the geographic impact of Shigeyasu Tsuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeyasu Tsuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeyasu Tsuda more than expected).
Fields of papers citing papers by Shigeyasu Tsuda
This network shows the impact of papers produced by Shigeyasu Tsuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeyasu Tsuda. The network helps show where Shigeyasu Tsuda may publish in the future.
Co-authorship network of co-authors of Shigeyasu Tsuda
This figure shows the co-authorship network connecting the top 25 collaborators of Shigeyasu Tsuda. A scholar is included among the top collaborators of Shigeyasu Tsuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeyasu Tsuda. Shigeyasu Tsuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 9 | |
| 6 | 1 | |
| 7 | 14 | |
| 8 | 1 | |
| 9 | 24 | |
| 10 | 38 | |
| 11 | 83 | |
| 12 | 1 | |
| 13 | 22 | |
| 14 | 166 | |
| 15 | 132 | |
| 16 | 5 | |
| 17 | 1 | |
| 18 | 8 | |
| 19 | [Intraoperative use of L-lactated Ringer's solution]. | 1 |
| 20 | [Clinical study of a new antibiotic, tuberactinomycin-N, in pulmonary tuberculosis]. | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.